Biocon Announcements
Intimation of Record Date for Commercial Paper
24 Dec, 2025 | 08:25pm • Source: BSE
Biocon Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through...
23 Dec, 2025 | 09:43am • Source: NSE
Press Release
23 Dec, 2025 | 09:09am • Source: BSE
Biocon Limited has informed the Exchange regarding a press release dated December 17, 2025, titled "Biocon Biologics Recognized as Asia IP Elite for 2025 by...
17 Dec, 2025 | 09:38am • Source: NSE
Press Release
17 Dec, 2025 | 08:09am • Source: BSE
Biocon Limited has informed the Exchange regarding a press release dated December 15, 2025, titled "Biocon Limited launches its Glucagon-like Peptide-1 (GLP -1), Liraglutide, in...
15 Dec, 2025 | 09:15am • Source: NSE
Press Release
15 Dec, 2025 | 08:33am • Source: BSE
Biocon Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "S&P Global Places Biocon Biologics on Positive CreditWatchOn Account of...
11 Dec, 2025 | 02:19pm • Source: NSE
Press Release
11 Dec, 2025 | 01:22pm • Source: BSE
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)
10 Dec, 2025 | 04:02pm • Source: BSE
Intimation regarding Credit Rating
10 Dec, 2025 | 01:18pm • Source: BSE
Investor Presentation
09 Dec, 2025 | 08:04pm • Source: BSE
Newspaper Publication
08 Dec, 2025 | 04:53pm • Source: BSE
Extra-Ordinary General Meeting scheduled to be held on Wednesday, December 31, 2025
07 Dec, 2025 | 02:17pm • Source: BSE
Outcome of Board Meeting - Raising of Funds through issuance of Commercial Papers
06 Dec, 2025 | 11:29am • Source: BSE
Outcome of Board Meeting - Raising of funds by way of issuance of any instrument or security in one or mode permissible modes
06 Dec, 2025 | 11:24am • Source: BSE
Outcome of Board Meeting - Preferential Issue
06 Dec, 2025 | 11:18am • Source: BSE